Intermed Discovery Overview
- Year Founded
-
2006
- Status
-
Out of Business
- Employees
-
25
- Latest Deal Type
-
Liquidation
Intermed Discovery General Information
Description
Researcher and developer of natural products for the life science industry. The company's technology platform can correlate chemical structures with biological activity on a large scale and thus identify novel active ingredients with defined applications. It generates proprietary product pipelines of early stage pharmaceuticals and functional ingredients for the life science, animal health, agrochemical, food and cosmetic industries.
Contact Information
Website
www.intermed-discovery.comCorporate Office
- Otto-Hahn-Street 15
- 44227 Dortmund
- Germany
Corporate Office
- Otto-Hahn-Street 15
- 44227 Dortmund
- Germany
Intermed Discovery Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Bankruptcy: Liquidation | 20-Dec-2012 | Completed | Bankruptcy: Liquidation | |||
| 4. Secondary Transaction - Private | 13-Jan-2009 | Completed | Startup | |||
| 3. Early Stage VC | 03-Mar-2008 | Completed | Startup | |||
| 2. Seed Round | 01-Jan-2006 | Completed | Startup | |||
| 1. Merger/Acquisition | 01-Jan-2006 | Completed | Startup |
Intermed Discovery Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Intermed Discovery Patents
Intermed Discovery Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20150050371-A1 | Extract formulations of rhodamnia cinerea and uses thereof | Inactive | 09-Mar-2012 | ||
| EP-2532232-A1 | Long chain glycolipids useful to avoid perishing or microbial contamination of materials | Inactive | 10-Jun-2011 | ||
| US-20130338219-A1 | Terpenoid spiro ketal compounds with lxr agonists activity, their use and formulations with them | Active | 14-Dec-2010 | ||
| EP-2468253-A1 | Terpenoid spiro ketal compounds with lxr agonists activity, their use and formulations with them | Inactive | 14-Dec-2010 | ||
| EP-2390343-A1 | Production of fatty acids by heterologous expression of gene clusters from myxobacteria | Inactive | 31-May-2010 | C12P7/6427 |
Intermed Discovery Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Intermed Discovery FAQs
-
When was Intermed Discovery founded?
Intermed Discovery was founded in 2006.
-
Who is the founder of Intermed Discovery?
Bernard Becker and Thomas Henkel are the founders of Intermed Discovery.
-
Where is Intermed Discovery headquartered?
Intermed Discovery is headquartered in Dortmund, Germany.
-
What is the size of Intermed Discovery?
Intermed Discovery has 25 total employees.
-
What industry is Intermed Discovery in?
Intermed Discovery’s primary industry is Agricultural Chemicals.
-
Is Intermed Discovery a private or public company?
Intermed Discovery is a Private company.
-
What is Intermed Discovery’s current revenue?
The current revenue for Intermed Discovery is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
